Skip to main content

Table 1 Each Patient Characteristics

From: A retrospective study of CT-guided percutaneous irreversible electroporation (IRE) ablation: clinical efficacy and safety

Patient No.

R.E.N.A.L nephrometry score

eGRF (mL/min)(preoperative)

eGRF (mL/min)(1-2 M after operative)

Haemoglobin(g/l)(preoperative)

Haemoglobin(g/l)(3-7D after operative)

Operation- related complications

Maximal tumordiameter (cm)

Tumor location

Number of electrodes

Follow-up (month)

Survival

1

7P

98.6

86.1

118

112

None

1.3

R- upper

2

32

Alive

2

8P

44.2

39.2

114

119

None

2.3

R- middle

4

43

Alive

3

9P

32.0

50.1

121

128

None

3.6

L-upper

4

42

Alive

4P

None

4.2

L-lower

4

4

8P

19.8

16.2

122

126

None

2.8

L-upper

4

41

Alive

5

6A

31.8

61.4

128

125

None

2.2

L-middle

3

36

Alive

6

6A

48.1

/

118

115

None

1.1

L-lower

2

33

Alive

7

5A

114.4

111.8

141

135

None

2.1

L- upper

4

32

Alive

8

5A

55.4

36.2

119

129

None

1.7

R-upper

3

30

Alive

9

6A

73.3

64.9

121

118

None

3.0

R-upper

4

28

Alive

10

5A

12.93

9.74

109

110

None

2.5

R-lower

3

24

Alive

9A

perinephric hematomas

4.5

L-lower

4

11

4A

37.8

43.6

129

120

Transient mild macroscopic hematuria

1.4

R-upper

3

14

Alive

8 Ah

2.0

R-central

3

12

8P

31.1

36

118

112

None

4.3

R-lower

4

12

Alive

13

6A

49.2

44

122

131

None

1.3

R-lower

2

11

Alive

14

7P

98.6

86.1

112

103

Transient macroscopic hematuria

1.3

L-central

2

14

Alive

15

6A

52.2

49.5

119

117

None

1.1

L-upper

2

12

Alive

6P

None

1.3

L-lower

2